Carl Zeiss Meditec AG

General ticker "CZMWF" information:

  • Sector: Health Care
  • Industry: Medical - Instruments & Supplies
  • Capitalization: $5.1B (TTM average)

Carl Zeiss Meditec AG does not follow the US Stock Market performance with the rate: -36.5%.

Estimated limits based on current volatility of 3.5%: low 27.67$, high 29.65$

Factors to consider:

  • Company pays dividends (annually): last record date 2025-03-28, amount 0.65$ (Y2.46%)
  • Current price 30.1% below estimated low
  • Earnings for 9 months up through Q3 are close to our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-09-30 to 2026-09-30

  • 2024-09-30 to 2025-09-30 estimated range: [39.07$, 83.19$]
  • 2025-09-30 to 2026-09-30 estimated range: [37.78$, 78.90$]

Financial Metrics affecting the CZMWF estimates:

  • Negative: with PPE of 30.1 at the end of fiscal year the price was high
  • Positive: -4.75 < Operating profit margin, % of 5.87
  • Positive: 42.68 < Shareholder equity ratio, % of 60.17 <= 64.29
  • Positive: Interest expense per share per price, % of 0.56 <= 0.73
  • Positive: Inventory ratio change, % of 0.69 <= 0.80
  • Negative: negative Industry operating cash flow (median)
  • Positive: 1.87 < Return on assets ratio (scaled to [-100,100]) of 5.04

Similar symbols

Short-term CZMWF quotes

Long-term CZMWF plot with estimates

Financial data

YTD 2023-09-30 2024-09-30 2025-09-30
Operating Revenue €2,089.30MM €2,066.13MM €2,227.64MM
Operating Expenses €1,762.16MM €1,944.78MM €2,004.33MM
Operating Income €327.14MM €121.35MM €223.32MM
Non-Operating Income €85.43MM €119.52MM €-29.43MM
Interest Expense €1.92MM €29.42MM €26.62MM
R&D Expense €349.28MM €343.09MM €326.27MM
Income(Loss) €412.56MM €240.87MM €193.89MM
Taxes €120.56MM €60.71MM €51.55MM
Profit(Loss)* €290.40MM €178.73MM €141.21MM
Stockholders Equity €2,159.45MM €2,041.70MM €2,116.51MM
Inventory €519.62MM €536.16MM €496.98MM
Assets €3,032.92MM €3,393.20MM €3,403.37MM
Operating Cash Flow €250.86MM €247.32MM €246.26MM
Capital expenditure €113.86MM €152.20MM €46.23MM
Investing Cash Flow €-110.98MM €-412.31MM €-106.81MM
Financing Cash Flow €-135.09MM €176.25MM €-127.70MM
Earnings Per Share** €3.25 €2.01 €1.61

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.